# Molecular Diagnosis in Hymenoptera Allergy: Comparison of Euroline DPA-Dx and ImmunoCAP

**Authors:** Lluís Marquès, Arantza Vega, Federico de la Roca, Carmen Domínguez, Víctor Soriano-Gomis, Teresa Alfaya, Laia Ferré-Ybarz, José-María Vega, Mario Tubella, Berta Ruiz-León

PMC · DOI: 10.3390/toxins17060310 · 2025-06-19

## TL;DR

This study compares two diagnostic tests for Hymenoptera allergy and finds differences in their accuracy, especially for Polistes venom.

## Contribution

The study highlights diagnostic discrepancies between Euroline® DPA-Dx and ImmunoCAP® for Hymenoptera allergy, particularly in Polistes venom detection.

## Key findings

- Euroline® and ImmunoCAP® agreed on results in only 50.99% of cases.
- ImmunoCAP® showed higher detection rates for Polistes dominula venom compared to Euroline®.
- Both tests performed similarly in diagnosing bee venom allergy but differed in wasp venom allergy.

## Abstract

The efficacy of Hymenoptera venom immunotherapy is contingent upon the accurate identification of the insect responsible for the allergic reaction. The techniques used to detect specific IgE suffer from difficulties due to the cross-reactivity between Hymenoptera venoms (false positives), diagnostic ability, and the limited availability of allergenic components (false negatives). In this study, we analyzed the discrepancies in the results obtained with Euroline® DPA-Dx and ImmunoCAP® in the diagnosis of allergic reactions due to Hymenoptera stings in 151 patients. The results (positive/negative) of ImmunoCAP® and Euroline® agreed in 77/151 (50.99%) cases; with 15/151 (9.93%) cases positive for the same insect, and 61/151 (40.4%) cases positive for multiple insects. When the results were used to decide which venom to use for immunotherapy, there was a statistically significant discrepancy for Polistes dominula (21.8% of cases with ImmunoCAP® compared to only 8.4% with Euroline®). The presence of Polistes venom phospholipase (Pol d 1) in Euroline® did not increase its ability to differentiate double sensitization to wasps. ImmunoCAP® and Euroline® exhibited comparable diagnostic performance in bee venom allergy. For vespid venom allergy—particularly involving Polistes species—ImmunoCAP® appeared to show a slight diagnostic advantage, although this finding should be interpreted with caution.

## Linked entities

- **Proteins:** POLD1 (DNA polymerase delta 1, catalytic subunit)
- **Species:** Polistes dominula (taxon 743375)

## Full-text entities

- **Diseases:** bee venom allergy (MESH:D000092422), Hymenoptera stings (MESH:D001733), Hymenoptera Allergy (MESH:D004342)
- **Species:** Homo sapiens (human, species) [taxon 9606], Hymenoptera (hymenopterans, order) [taxon 7399]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12197634/full.md

---
Source: https://tomesphere.com/paper/PMC12197634